DNA Jewel to Finance Anti-Aging Services & Cancer Research
Geneva (ots) - Swiss-based www.dnartistic.com's first piece of DNA luxury jewellery will be sold at 1 million CHF and some of the proceeds will be used to finance the anti-aging services and life extension research of sister company www.inneova.com.
Dr. Ivan de Weber, a young Swiss scientist specialized in molecular genetics of aging and co-founder of both Inneova™ and DNArtistic has brought together a group of jewellers who work with the world's most exclusive brands including Chopard and Bulgari. They will integrate the DNA and genetic fingerprint of the jewel's future owner into the object via a fusion of molecular biology and jewellery-making.
DNArtistic already uses the concept of DNA identification to offer its clients DNA-inspired paintings. Similar technology allows clients to explore their ancestral origins at www.dnapast.com.
Inneova™, one of the first companies worldwide, provides adult cell cryobanking services to preserve human cells from the aging process. As cells deteriorate with age, Inneova™ allows its adult clients to freeze either their skin or bone cells (for newborns, umbilical cord cells), banking their "youth potential" for use in future anti-aging, rejuvenation and regeneration treatments.
Inneova™ also offers the most comprehensive range of predictive genetic tests available worldwide. These screen for risk factors and sensitivity to particular molecules to help physicians recommend further check-ups and optimize the choice of medications, diets, and cosmetics. In association with Knome™ Inneova™ offers whole genome sequencing, considered the most advanced genetic tool in predictive medicine.
To assure a complete range of anti-aging services, Inneova™ provides access to genetic counselling and anti-aging medical practices (including molecular check-ups, advanced hormone replacement therapy as well as cutting-edge plastic and cosmetic surgery) through its extensive international network of specialized physicians.
Dr. Ivan de Weber